97 related articles for article (PubMed ID: 17958944)
21. Patient-Centred Outcomes in Anaemia and Renal Disease: A Systematic Review.
Staibano P; Perelman I; Lombardi J; Davis A; Tinmouth A; Carrier M; Stevenson C; Saidenberg E
Kidney Dis (Basel); 2020 Mar; 6(2):74-84. PubMed ID: 32309289
[TBL] [Abstract][Full Text] [Related]
22. Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron.
Strauss WE; Auerbach M
Patient Relat Outcome Meas; 2018; 9():285-298. PubMed ID: 30214332
[TBL] [Abstract][Full Text] [Related]
23. Measurement properties of the Short Form-36 (SF-36) and the Functional Assessment of Cancer Therapy - Anemia (FACT-An) in patients with anemia associated with chronic kidney disease.
Finkelstein FO; van Nooten F; Wiklund I; Trundell D; Cella D
Health Qual Life Outcomes; 2018 May; 16(1):111. PubMed ID: 29855366
[TBL] [Abstract][Full Text] [Related]
24. Consequences of CKD on Functioning.
Kittiskulnam P; Sheshadri A; Johansen KL
Semin Nephrol; 2016 Jul; 36(4):305-18. PubMed ID: 27475661
[TBL] [Abstract][Full Text] [Related]
25. Family income is associated with quality of life in patients with chronic kidney disease in the pre-dialysis phase: a cross sectional study.
Lemos CF; Rodrigues MP; Veiga JR
Health Qual Life Outcomes; 2015 Dec; 13():202. PubMed ID: 26690667
[TBL] [Abstract][Full Text] [Related]
26. Anemia has a negative impact on self-rated health in kidney transplant recipients with well-functioning grafts: findings from an 8-year follow-up study.
Majernikova M; Rosenberger J; Prihodova L; Marcelli D; Roland R; Groothoff JW; van Dijk JP
Qual Life Res; 2016 Jan; 25(1):183-92. PubMed ID: 26169231
[TBL] [Abstract][Full Text] [Related]
27. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.
Palmer SC; Saglimbene V; Mavridis D; Salanti G; Craig JC; Tonelli M; Wiebe N; Strippoli GF
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010590. PubMed ID: 25486075
[TBL] [Abstract][Full Text] [Related]
28. Darbepoetin for the anaemia of chronic kidney disease.
Palmer SC; Saglimbene V; Craig JC; Navaneethan SD; Strippoli GF
Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD009297. PubMed ID: 24683046
[TBL] [Abstract][Full Text] [Related]
29. Health related quality of life in Iranian hemodialysis patients with viral hepatitis: changing epidemiology.
Rostami Z; Lessan Pezeshki M; Soleimani Najaf Abadi A; Einollahi B
Hepat Mon; 2013; 13(6):e9611. PubMed ID: 24032050
[TBL] [Abstract][Full Text] [Related]
30. Not so benign haematology: anaemia of the elderly.
Merchant AA; Roy CN
Br J Haematol; 2012 Jan; 156(2):173-85. PubMed ID: 22050828
[TBL] [Abstract][Full Text] [Related]
31. Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial.
Lewis EF; Pfeffer MA; Feng A; Uno H; McMurray JJ; Toto R; Gandra SR; Solomon SD; Moustafa M; Macdougall IC; Locatelli F; Parfrey PS;
Clin J Am Soc Nephrol; 2011 Apr; 6(4):845-55. PubMed ID: 21212421
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life outcomes in chronic kidney disease.
Soni RK; Weisbord SD; Unruh ML
Curr Opin Nephrol Hypertens; 2010 Mar; 19(2):153-9. PubMed ID: 20051850
[TBL] [Abstract][Full Text] [Related]
33. Every-other-week darbepoetin alfa in the correction and maintenance of haemoglobin levels in elderly patients with chronic kidney disease: post hoc subanalysis of data from two clinical trials.
Krause MW; Raja R; Agarwal A; Silver MR; Scarlata D; Sciarra A; Kewalramani R
Drugs Aging; 2009; 26(8):665-75. PubMed ID: 19685932
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life in CKD Patients: correlates and evolution over time.
Mujais SK; Story K; Brouillette J; Takano T; Soroka S; Franek C; Mendelssohn D; Finkelstein FO
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1293-301. PubMed ID: 19643926
[TBL] [Abstract][Full Text] [Related]
35. Predialysis chronic kidney disease: evaluation of quality of life in clinic patients receiving comprehensive anemia care.
Hansen RA; Chin H; Blalock S; Joy MS
Res Social Adm Pharm; 2009 Jun; 5(2):143-53. PubMed ID: 19524862
[TBL] [Abstract][Full Text] [Related]
36. Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agents.
Silver MR; Geronemus R; Krause M; Chen CY; Kewalramani R; Stehman-Breen C
Curr Med Res Opin; 2009 Jan; 25(1):123-31. PubMed ID: 19210145
[TBL] [Abstract][Full Text] [Related]
37. Association of anemia correction with health related quality of life in patients not on dialysis.
Alexander M; Kewalramani R; Agodoa I; Globe D
Curr Med Res Opin; 2007 Dec; 23(12):2997-3008. PubMed ID: 17958944
[TBL] [Abstract][Full Text] [Related]
38. Quality of life improvements in dialysis patients receiving darbepoetin alfa.
Fukuhara S; Akizawa T; Morita S; Koshikawa S;
Ther Apher Dial; 2008 Feb; 12(1):72-7. PubMed ID: 18257816
[TBL] [Abstract][Full Text] [Related]
39. Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease.
Joy MS; Candiani C; Vaillancourt BA; Chin H; Hogan SL; Falk RJ
Pharmacotherapy; 2007 May; 27(5):734-44. PubMed ID: 17461709
[TBL] [Abstract][Full Text] [Related]
40. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
